Elsevier

Life Sciences

Volume 54, Issue 22, 1994, Pages 1671-1680
Life Sciences

Serotonin-induced contraction in canine coronary artery and saphenous vein: Role of a 5-HT1D-like receptor

https://doi.org/10.1016/0024-3205(94)00607-5Get rights and content

Abstract

The identity of the serotonin (5-HT) receptor(s) that mediate(s) contraction in canine coronary artery and saphenous vein remains controversial. Ring segments of endothelium-denuded coronary artery and helical strips of saphenous vein were suspended in organ chambers for measurement of isometric force. 5-HT, αMe-5-HT and sumatriptan contracted both coronary artery and saphenous vein and the non-selective 5-HT receptor antagonist 1-naphthylpiperazine (100nM) blocked 5-HT-and sumatriptan-induced contraction in both tissues. The agonist rank order potency for contraction (5-HT>sumatriptan>αMe5-HT>5-MeOT>5-MeT) was similar in both tissues and was consistent with that for a 5-HT1D receptor. Oligonucleotide primers specific for the 5-HT1D receptor sequence were designed for use in a polymerase chain reaction (PCR). cDNA derived from total RNA or mRNA from canine tissues was used in the PCR. PCR resulted in the amplification of a 632 base pair sequence in both canine coronary artery and saphenous vein; consistent with that expected for the 5-HT1D receptor. Southern blot analysis, with an oligonucleotide probe internal to the sequence amplified by the PCR primers, confirmed that the sequence amplified by PCR was the 5-HT1D receptor. Thus, the 5-HT1D receptor is expressed in canine coronary artery and saphenous vein and taken together with the pharmacological data, supports the possibility that a 5-HT1D-like receptor mediates contraction in these two tissues.

References (26)

  • M.L. Cohen et al.

    Eur. J. Pharmacol.

    (1992)
  • M.A. Moskowitz

    Trends Pharmacol Sci.

    (1992)
  • C. Maenhaut et al.

    Biochem. Biophys. Res. Comm.

    (1991)
  • M.I.M. Noble et al.

    Coronary Artery Disease

    (1990)
  • T.J. Verbeuren

    Coronary Artery Disease

    (1991)
  • P. Golino et al.

    N. Engl. J. Med.

    (1991)
  • E.P. McFadden et al.

    N. Engl. J. Med.

    (1991)
  • J.E. Connor et al.

    Eur. J. Pharmacol.

    (1989)
  • A.H. Chester et al.

    Cardiovasc. Res.

    (1990)
  • A.H. Chester et al.

    Circulation

    (1993)
  • E.P. McFadden et al.

    Circulation

    (1992)
  • P.P.A. Humphrey et al.

    Br. J. Pharmacol.

    (1989)
  • D.J. Cushing et al.

    J. Pharmacol. Exptl. Ther.

    (1992)
  • Cited by (28)

    • 5-HT(1B/D) receptor antagonists

      1997, General Pharmacology
    View all citing articles on Scopus
    1

    Present address: Astra-Merck Group, Providence Rhode Island 02903

    View full text